Covered recipient · General Payments record
TIMOTHY VARTANIAN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$613,658.19
- Reported across 419 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $15,257.00 | 6 |
| Travel and Lodging | $716.09 | 3 |
| Food and Beverage | $85.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $11,614.09 | 6 |
| Genentech, Inc. | $3,105.00 | 2 |
| SANOFI-AVENTIS U.S. LLC | $1,168.00 | 1 |
| Biogen, Inc. | $171.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Biogen, Inc. | $171.00 | 04/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104809937 | CMS |
| Genentech, Inc. | $1,035.00 | 07/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133126007 | CMS |
| Genentech, Inc. | $2,070.00 | 12/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133126011 | CMS |
| GENZYME CORPORATION | $1,168.00 | 01/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139680607 | CMS |
| GENZYME CORPORATION | $85.00 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139680661 | CMS |
| GENZYME CORPORATION | $202.92 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139680663 | CMS |
| GENZYME CORPORATION | $331.00 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139680665 | CMS |
| GENZYME CORPORATION | $182.17 | 11/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1139680667 | CMS |
| GENZYME CORPORATION | $9,645.00 | 11/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139680669 | CMS |
| SANOFI-AVENTIS U.S. LLC | $1,168.00 | 01/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1139680521 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.